About Huntress Labs
Huntress Labs is a private company based in Columbia, Maryland. It has reported $292,146,639 raised in four offerings on Form D since March 2020. Its chief executive is Kyle Hanslovan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 7, 2024 | Jun 20, 2024 | $180,000,000fully sold | 8 | $22.5M | Equity, Preferred Stock can convert to underlying shares of Common Stock.Rule 506(b) | Form D ↗ |
| Apr 20, 2023 | May 23, 2023 | $59,999,992fully sold | 5 | $11.9M | Equity, Preferred Stock can convert to underlying shares of Common Stock.Rule 506(b) | Form D ↗ |
| Apr 30, 2021 | May 17, 2021 | $39,999,990fully sold | 5 | $7.9M | Equity, Preferred Stock can convert to underlying shares of Common Stock.Rule 506(b) | Form D ↗ |
| Feb 18, 2020 | Mar 4, 2020 | $12,146,657of $12.1M target | 16 | $759K | Equity, Preferred Stock can convert to underlying shares of Common Stock.Rule 506(b) | Form D ↗ |
| Total, four offerings | $292,146,639 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Huntress Labs's Form D filed Jun 20, 2024.
MT
Marcos Torres
Executive officer
KH
Kyle Hanslovan
Chief Executive Officer and director
EB
Ernie Bio
Director
CB
Christopher Bisnett
Executive officer and director
AK
Alex Kurland
Director
JF
John Ferrell
Executive officer
BA
Brian Arnold
Executive officer
ER
Everett Randle
Director
CW
Casber Wang
Director
SV
Suken Vakil
Director